Kestra Medical Technologies (KMTS) Income towards Parent Company (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Income towards Parent Company data on file, last reported at $77.3 million in Q2 2026.

• On a quarterly basis, Income towards Parent Company rose 267.07% year-over-year to $77.3 million in Q2 2026; TTM through Apr 2026 was -$15.5 million, a 85.81% increase from a year earlier, with the FY2026 full-year figure at -$15.5 million, up 85.81% from the prior year.
• Income towards Parent Company for Q2 2026 stood at $77.3 million, up from -$34.2 million in the prior quarter.
• Over the last five years, Income towards Parent Company for KMTS reached as high as $77.3 million in Q2 2026 and fell as low as -$46.3 million in Q2 2025.
• Historically, Income towards Parent Company has averaged -$16.6 million across 3 years, with a median of -$21.7 million in 2024.
• Across the five-year window, Income towards Parent Company tumbled 132.13% in 2025 and soared 267.07% in 2026, its largest moves.
• Year by year, Income towards Parent Company stood at -$20.6 million in 2024, then plunged by 58.99% to -$32.8 million in 2025, then surged by 335.82% to $77.3 million in 2026.
• Per Business Quant data, the three most recent Income towards Parent Company figures were $77.3 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.